The solution helps health systems to take a step-by-step approach to manage risk from population- to patient-level with easy to use dashboards powered by clinical and claims data. First, it helps understand the current state of risk management in the network with historical comparison to previous years risk scores. Second, it can answer “where to focus” by identifying the cohorts with the least risk recapture rates or maximum dropped/suspect codes, chronic disease distribution, month on month risk capture trend and more. Third, it helps prioritize patients with the largest number of coding gaps and get patient-level risk information to redirect resources strategically that reduces overall risk for the population.

Innovaccer is the data platform that accelerates care innovation through innovative AI technologies. Innovaccer’s AI-powered healthcare platform unifies patient data across systems and care settings, and empowers healthcare organizations with scalable, modern applications that improve clinical, financial, operational, and experiential outcomes. Innovaccer’s EHR-agnostic solutions have been deployed across more than 1,600 hospitals and clinics in the US, enabling care delivery transformation for more than 96,000 clinicians, and helping providers work collaboratively with payers and life sciences companies. Innovaccer has helped its customers unify health records for more than 54 million people and generate over $1.5 billion in cumulative cost savings. The Innovaccer platform is an industry-leading data and analytics platform, the Best in KLAS CRM solution, and the #1 rated population health technology platform by Black Book

Web-based clinical intelligence platform, primarily utilized in critical care units to guide clinical decisions. The platform has full interoperability with the Electronic Health Record, and combines all relevant data within the complex critical care environment into one visualization to provide a full picture of a patient and their longitudinal trends. FDA-cleared algorithms continually assess the incoming patient information and provide early warning signs of clinical deterioration to aid care teams with determining interventions and treatment. Automated clinical workflows, customized to each individual ICU, provide care efficiency and positively impact clinical outcomes. 

Published clinical outcomes showing:

• Up to 36% reduction in ICU length of stay
• 41% reduction in ICU readmissions
• 22% reduction in time on ventilation
• 18% reduction in time on vasoactive medication

Commercial stage company with market leading AI clinical decision support platform for bedside and remote monitoring of high acuity patients. Published outcomes and strong ROI; utilized in 40+ hospitals & health systems.

Innovaccer's coder assistant identifies missing codes based on claims data and suggested clinical markers, helping avoid improper data submission and related consequences such as lengthy audits and repayments to CMS. The solution enables physicians and coders to save time by identifying information that could not be directly found in the patient's clinical or claims data. Failing audits, repayments to CMS, and legal ramifications are some of the unfortunate outcomes of improper data submission. Automation helps overcome these challenges by detecting suspect and dropped codes while reducing administrative burden.

Innovaccer’s risk management solutions support these efforts to help healthcare providers achieve their risk goals. The AI-powered coder assistant helps providers address coding challenges by analyzing dropped codes and reviewing claims data over multiple years to identify prospective coding opportunities and surface suspect codes based on evidence. This enables them to receive appropriate reimbursements by providing high-quality care to patients

Etiometry provides functionality to seamlessly extend the EHR to be effective for care in high-acuity patient settings (e.g. ICU), including automating clinical workflows, and providing in-depth, longitudinal trends.

Etiometry is the only CDS platform with 4 FDA-cleared risk algorithms and the platform's data collection capabilities have led to a vastly larger number of supporting clinical studies (>150).